These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22927453)

  • 1. GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapy.
    Bhattarai N; Rydze RT; Chivero ET; Stapleton JT
    J Infect Dis; 2012 Nov; 206(9):1469-72. PubMed ID: 22927453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals.
    Stapleton JT; Chaloner K; Martenson JA; Zhang J; Klinzman D; Xiang J; Sauter W; Desai SN; Landay A
    PLoS One; 2012; 7(11):e50563. PubMed ID: 23209780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell death.
    Rydze RT; Bhattarai N; Stapleton JT
    Antivir Ther; 2012; 17(7):1271-9. PubMed ID: 22951385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.
    Stapleton JT; Chaloner K; Zhang J; Klinzman D; Souza IE; Xiang J; Landay A; Fahey J; Pollard R; Mitsuyasu R
    AIDS; 2009 Mar; 23(5):605-10. PubMed ID: 19194270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.
    Brumme ZL; Chan KJ; Dong WW; Mo T; Wynhoven B; Hogg RS; Montaner JS; O'Shaughnessy MV; Harrigan PR
    AIDS; 2002 Sep; 16(14):1929-33. PubMed ID: 12351953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.
    Tassiopoulos K; Landay A; Collier AC; Connick E; Deeks SG; Hunt P; Lewis DE; Wilson C; Bosch R
    J Infect Dis; 2012 Jun; 205(11):1730-8. PubMed ID: 22448010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GB virus type C infection modulates T-cell activation independently of HIV-1 viral load.
    Maidana-Giret MT; Silva TM; Sauer MM; Tomiyama H; Levi JE; Bassichetto KC; Nishiya A; Diaz RS; Sabino EC; Palacios R; Kallas EG
    AIDS; 2009 Nov; 23(17):2277-87. PubMed ID: 19773635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
    AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
    Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells.
    Schwarze-Zander C; Neibecker M; Othman S; Tural C; Clotet B; Blackard JT; Kupfer B; Luechters G; Chung RT; Rockstroh JK; Spengler U
    Antivir Ther; 2010; 15(5):745-52. PubMed ID: 20710056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile.
    Nunnari G; Nigro L; Palermo F; Attanasio M; Berger A; Doerr HW; Pomerantz RJ; Cacopardo B
    Ann Intern Med; 2003 Jul; 139(1):26-30. PubMed ID: 12834315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.
    Chang JJ; Wightman F; Bartholomeusz A; Ayres A; Kent SJ; Sasadeusz J; Lewin SR
    J Virol; 2005 Mar; 79(5):3038-51. PubMed ID: 15709024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; Morsica G; Pizzaferri P; Ladisa N; Sighinolfi L; Chiodera A; Solmone M; Lalle E; Ippolito G; Monforte Ad; ;
    Antivir Ther; 2005; 10(1):109-17. PubMed ID: 15751768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD26 and CD30 plasma levels in HIV infected patients with and without GB virus type C coinfection.
    Mostafa HM; Ali-Akbar P; Zahra S; Minoo M; Sedigheh A; Mahnaz A; Shahram S; Mahin N; Mina M
    Pak J Biol Sci; 2007 Jun; 10(12):2014-9. PubMed ID: 19093441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GBV-C viremia and clinical events in advanced HIV infection.
    Sahni H; Kirkwood K; Kyriakides TC; Stapleton J; Brown ST; Holodniy M;
    J Med Virol; 2014 Mar; 86(3):426-32. PubMed ID: 24249700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GB virus C replicates in primary T and B lymphocytes.
    George SL; Varmaz D; Stapleton JT
    J Infect Dis; 2006 Feb; 193(3):451-4. PubMed ID: 16388494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
    Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy.
    Alcalde R; Nishiya A; Casseb J; Inocêncio L; Fonseca LA; Duarte AJ
    Virus Res; 2010 Aug; 151(2):148-52. PubMed ID: 20420864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In HIV-infected patients, some differential alterations of CD4 and CD8 T cell homeostasis may not be restored by ≥ 7 years of highly active antiretroviral therapy, in spite of good CD4 T cell repopulation.
    Bordoni V; Agrati C; Rinaldi A; Viola D; De Simone G; Gioia C; Martini F
    J Antimicrob Chemother; 2012 Jul; 67(7):1802-4. PubMed ID: 22461310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.